HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chihiro Tanaka Selected Research

radixin

4/2022Ezrin Contributes to the Plasma Membrane Expression of PD-L1 in A2780 Cells.
4/2022Ezrin Regulates the Cell Surface Localization of PD-L1 in HEC-151 Cells.
9/2021Contribution of Ezrin on the Cell Surface Plasma Membrane Localization of Programmed Cell Death Ligand-1 in Human Choriocarcinoma JEG-3 Cells.
8/2021Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells.
1/2021Subcellular distribution of ezrin/radixin/moesin and their roles in the cell surface localization and transport function of P-glycoprotein in human colon adenocarcinoma LS180 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chihiro Tanaka Research Topics

Disease

11Neoplasms (Cancer)
04/2022 - 06/2003
11Hypertension (High Blood Pressure)
06/2007 - 01/2004
10Colorectal Neoplasms (Colorectal Cancer)
08/2021 - 06/2016
6Neoplasm Metastasis (Metastasis)
02/2019 - 06/2003
5Colonic Neoplasms (Colon Cancer)
08/2021 - 12/2010
5Infections
01/2011 - 09/2004
4Systemic Scleroderma (Systemic Sclerosis)
11/2010 - 10/2007
4Atherosclerosis
06/2005 - 04/2004
3Stomach Neoplasms (Stomach Cancer)
09/2012 - 01/2008
3Rheumatoid Arthritis
06/2012 - 01/2009
3Hyperlipidemias (Hyperlipidemia)
08/2006 - 01/2004
3Carotid Artery Diseases
06/2005 - 04/2004
2Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2022 - 09/2021
2Adenocarcinoma
09/2021 - 08/2021
2Carcinoma (Carcinomatosis)
09/2021 - 02/2016
2Rupture
03/2021 - 12/2011
2Starvation
01/2017 - 01/2017
2Mycoses (Diseases, Fungus)
01/2011 - 11/2004
2Lymphatic Metastasis
12/2010 - 06/2010
2Fibrosis (Cirrhosis)
06/2010 - 06/2010
2Diabetes Mellitus
05/2005 - 01/2004
2Pseudohypoaldosteronism
05/2004 - 01/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2022
1Ovarian Epithelial Carcinoma
04/2022
1Ovarian Neoplasms (Ovarian Cancer)
04/2022
1Endometrial Neoplasms (Endometrial Cancer)
04/2022
1Rectal Neoplasms (Rectal Cancer)
12/2021
1Choriocarcinoma
09/2021
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
09/2021
1Obesity
04/2020
1Diarrhea
01/2018
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2016
1Hypoglycemia (Reactive Hypoglycemia)
08/2015
1Arthralgia (Joint Pain)
11/2010

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
07/2022 - 06/2003
6moesinIBA
07/2022 - 01/2021
6Immune Checkpoint InhibitorsIBA
07/2022 - 08/2021
6ezrinIBA
04/2022 - 01/2021
6Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2021 - 06/2016
5radixinIBA
04/2022 - 01/2021
4Immune Checkpoint ProteinsIBA
04/2022 - 08/2021
3XELOXIBA
01/2017 - 06/2016
3Antihypertensive Agents (Antihypertensives)IBA
08/2006 - 01/2004
2AntibodiesIBA
04/2022 - 09/2021
2Leucovorin (Folinic Acid)FDA Link
01/2020 - 02/2017
2Irinotecan (Camptosar)FDA LinkGeneric
04/2019 - 01/2018
2Monoclonal AntibodiesIBA
01/2017 - 12/2016
2NitrogenIBA
01/2017 - 06/2003
2EnzymesIBA
02/2016 - 04/2006
2Methotrexate (Mexate)FDA LinkGeneric
06/2012 - 01/2009
2Tryptophan (L-Tryptophan)FDA Link
01/2011 - 05/2008
2Polysaccharides (Glycans)IBA
01/2008 - 06/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2007 - 06/2003
2SodiumIBA
04/2006 - 05/2004
2Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
04/2006 - 09/2005
1B7-H1 AntigenIBA
09/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
04/2020
1CreatinineIBA
04/2020
1Carboplatin (JM8)FDA LinkGeneric
04/2020
1Hemoglobins (Hemoglobin)IBA
04/2020
1TegafurIBA
01/2020
1UracilIBA
01/2020
1Panitumumab (Vectibix)FDA Link
04/2019
1lactate dehydrogenase 4IBA
04/2019
1Carcinoembryonic AntigenIBA
04/2019
1IsoenzymesIBA
04/2019
1lactate dehydrogenase 1 (LDH1)IBA
04/2019
1Bevacizumab (Avastin)FDA Link
01/2018
1Fluorouracil (Carac)FDA LinkGeneric
02/2017
1Cetuximab (Erbitux)FDA Link
02/2017
17-(N-(3-aminopropyl)amino)heptan-2-oneIBA
01/2017
1P(1),P(5)- di(adenosine- 5'- )pentaphosphateIBA
01/2017
1AgarIBA
01/2017
1diadenosine tetraphosphateIBA
01/2017
1Capecitabine (Xeloda)FDA Link
06/2016
1BilirubinIBA
02/2016
1N-dodecanoylglutamic acidIBA
08/2015
1Glucose (Dextrose)FDA LinkGeneric
08/2015
1Adalimumab (Humira)FDA Link
06/2012
1Antirheumatic Agents (DMARD)IBA
06/2012
1tryptamineIBA
01/2011
1Aromatic-L-Amino-Acid DecarboxylasesIBA
01/2011
1Rheumatoid FactorIBA
11/2010
1cyclic citrullinated peptideIBA
11/2010
1Anti-Citrullinated Protein AntibodiesIBA
11/2010

Therapy/Procedure

11Therapeutics
07/2022 - 11/2004
6Drug Therapy (Chemotherapy)
09/2021 - 12/2010
2Hepatectomy
02/2019 - 01/2008
2Gastrectomy
09/2012 - 01/2008
2Cryosurgery
01/2008 - 06/2003
1Chemoradiotherapy
12/2021
1Surgical Instruments (Clip)
03/2021
1Adjuvant Chemotherapy
01/2020
1Palliative Care (Palliative Therapy)
02/2019
1Neoadjuvant Therapy
01/2017
1Colectomy
02/2016
1Sutures (Suture)
12/2011
1Radiotherapy
12/2010